Copyright
©The Author(s) 2025.
World J Gastrointest Pharmacol Ther. Dec 5, 2025; 16(4): 111082
Published online Dec 5, 2025. doi: 10.4292/wjgpt.v16.i4.111082
Published online Dec 5, 2025. doi: 10.4292/wjgpt.v16.i4.111082
Figure 1 Bidirectional mechanisms of gut microbiota in obesity regulation.
The immune pathway involves B cells, T cells, dendritic cells, neutrophils, and macrophages. The neuroactive substance pathway includes metabolites such as gamma-aminobutyric acid, short-chain fatty acids, and tryptophan. The microbial pathway encompasses microbiota-derived signals. The endocrine pathway features gut peptides such as peptide YY and glucagon-like peptide-1 secreted by enteroendocrine cells. The neural pathway is mediated by the vagus nerve. The hypothalamic-pituitary-adrenal axis involves corticotropin-releasing factor, adrenocorticotropic hormone, and cortisol, which interact with gut hormones to regulate physiological processes.
- Citation: Wang SY, Zhang MZ, Chen ZM, Li ZM, Xie CY, Yang GH, Xu B, Xu TC. Intestinal-related substances in obesity regulation: A comprehensive review. World J Gastrointest Pharmacol Ther 2025; 16(4): 111082
- URL: https://www.wjgnet.com/2150-5349/full/v16/i4/111082.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v16.i4.111082
